Table 3.
GAG | aPTT (μg·mL−1) | PT (μg·mL−1) | BACE1 Inhibitory Activity (μg·mL−1) | Therapeutic Ratio |
---|---|---|---|---|
PMIH | 1.66 | 19.53 | 2.43 | 0.68 |
L.vannamei (F4) | 27.91 | 1276.00 | 4.61 | 6.10 |
L.vannamei (F5) | 14.60 | 138.80 | 5.93 | 2.46 |
GAG | aPTT (μg·mL−1) | PT (μg·mL−1) | BACE1 Inhibitory Activity (μg·mL−1) | Therapeutic Ratio |
---|---|---|---|---|
PMIH | 1.66 | 19.53 | 2.43 | 0.68 |
L.vannamei (F4) | 27.91 | 1276.00 | 4.61 | 6.10 |
L.vannamei (F5) | 14.60 | 138.80 | 5.93 | 2.46 |